share_log

Press Release: Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

Press Release: Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

新聞稿:前瞻收購公司(納斯達克代碼:FORE)和P3健康合作伙伴宣佈休會擬議的業務合併特別會議
Dow Jones Newswires ·  2021/11/24 23:40

Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

前瞻收購公司(納斯達克代碼:FORE)和P3健康合作伙伴宣佈休會擬議的業務合併特別會議

Special meeting of Foresight Acquisition Corp. stockholders to approve the proposed business combination adjourned to Friday, December 3, 2021, at 7:00 a.m. Central Time

Foresight Acquisition Corp.股東批准擬議中的業務合併的特別會議延期至2021年12月3日(星期五)上午7點。中部時間

NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ: FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned until 7:00 a.m. Central Time on December 3, 2021.

亞洲網紐約11月24日電(環球通訊社)--展望收購公司(納斯達克代碼:FORE)(下稱“展望公司”)宣佈,該公司股東特別會議(“特別會議”)與最初於美國東部時間上午9點召開的擬議中的與P3健康夥伴公司(P3)的業務合併(“業務合併”)有關。2021年11月18日中部時間,今天上午7點重新召開會議,今天休會到今天。中部時間,繼續休會至上午7點。中部時間2021年12月3日。

As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional time to file a proxy supplement to the definitive proxy statement that was filed with the Securities and Exchange Commission ("SEC") on October 28, 2021 (the "Proxy Statement") and mailed to Foresight's stockholders, and to provide Foresight's stockholders additional time to review and consider the information to be set forth in such proxy supplement. The proxy supplement will contain revised Unaudited Pro Forma Financial Statements reflecting changes related to the previously disclosed determination that the Business Combination should be accounted for as a business combination using the acquisition method of accounting rather than as a reverse recapitalization as currently provided for in the Unaudited Pro Forma Financial Statements contained in the Proxy Statement. As previously disclosed, these changes will have no impact on the historical financial statements of P3 or Foresight that were included in the Proxy Statement. Foresight expects to file the proxy supplement on or about Monday, November 29, 2021.

正如預期的那樣,特別會議被進一步休會,以便讓Foresight和P3有更多時間對2021年10月28日提交給證券交易委員會(“美國證券交易委員會”)並郵寄給Foresight股東的最終委託書(“委託書”)提交委託書附錄,並讓Foresight的股東有更多時間審查和考慮將在該委託書副刊中闡述的信息。委託書副刊將包含經修訂的未經審計的預計財務報表,反映與先前披露的確定業務合併應按收購會計方法入賬有關的變化,而不是代理報表中包含的未經審計的預計財務報表中目前規定的反向資本重組。正如之前披露的那樣,這些變化不會對委託書中包括的P3或Foresight的歷史財務報表產生影響。Presight預計將於2021年11月29日(星期一)左右提交委託書補充文件。

No changes have been made to the record date, the location of the meeting or the proposals to be voted on at the Special Meeting, which are presented in the Proxy Statement filed with the SEC on October 28, 2021. The re-convened meeting will be held virtually at https://www.cstproxy.com/foresightacq/2021. Only the holders of Foresight's common stock as of the close of business on October 8, 2021, the record date for the Special Meeting, are entitled to vote at the Special Meeting.

在2021年10月28日提交給美國證券交易委員會的委託書中,記錄日期、會議地點或將在特別會議上表決的提案沒有任何變化。重新召開的會議實際上將在https://www.cstproxy.com/foresightacq/2021.舉行。只有截至2021年10月8日,也就是特別會議的創紀錄日期收盤時,Foresight公司普通股的持有者才有權在特別會議上投票。

If you have already submitted your proxy, you do not need to take any action unless you wish to change your vote. You retain the power to revoke your proxy or change your vote at any time before it is voted at the Special Meeting on December 3, 2021. Only the most recent proxy vote will be counted and all others will be discarded regardless of the method of voting. If a broker or other nominee holds your stock on your behalf, you must contact your broker, bank or other nominee to change your vote. As a result of the adjournment, Foresight stockholders will be able to continue to change their redemption election on or prior to 5:00 p.m. Eastern Time on Wednesday, December 1, 2021.

如果你已經提交了你的委託書,你不需要採取任何行動,除非你想改變你的投票。您保留在2021年12月3日的特別會議上投票前的任何時間撤銷您的委託書或更改您的投票的權力。無論採用何種投票方式,都將只計算最近的代理投票,其他所有投票都將被丟棄。如果經紀人或其他被提名人代表您持有您的股票,您必須聯繫您的經紀人、銀行或其他被提名人來更改您的投票。由於休會,Foresight股東可以在下午5點或之前繼續更改他們的贖回選擇。美國東部時間2021年12月1日(星期三)。

If the proposals at the Special Meeting are approved, Foresight anticipates that the Business Combination will close as promptly as practicable after the Special Meeting, subject to the satisfaction or waiver (as applicable) of all other closing conditions.

如果特別會議上的建議獲得批准,Foresight預計業務合併將在特別會議後儘可能迅速地結束,前提是所有其他結束條件得到滿足或豁免(視情況而定)。

About Foresight Acquisition Corp.

關於Foresight Acquisition Corp.

Foresight is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit foresightacq.com.

遠見是為與一家或多家企業進行合併、資本換股、資產收購、股票購買、重組或類似業務合併而成立的特殊目的收購公司。欲瞭解更多信息,請訪問Foresightacq.com。

About P3 Health Partners

關於P3健康合作伙伴

P3 is a patient-centered and physician-led population health management company. Founded and led by physicians, P3 is a team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care. We leverage our deeply integrated and capital efficient care model, data and technology, physician leadership and community outreach tools to create enhanced patient outcomes and experiences, greater satisfaction for providers and caregivers and lower care costs. For more information, visit p3hp.org.

P3是一家以患者為中心,以醫生為主導的人羣健康管理公司。P3由醫生創建和領導,是一個由醫生、臨牀醫生和支持服務專業人員組成的團隊,他們對提供基於價值的護理有着共同的熱情。我們利用我們深度集成和資本效率高的護理模式、數據和技術、醫生領導力和社區推廣工具來創造更好的患者結果和體驗、更高的提供者和護理者滿意度以及更低的護理成本。欲瞭解更多信息,請訪問p3hp.org。

Forward-Looking Statements

前瞻性陳述

The information in this press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the expected changes to the pro forma financial information in the Proxy Statement, estimates and forecasts of financial and performance metrics and expectations and timing related to potential benefits, terms and timing of the transaction. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of P3's and Foresight's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of P3 and Foresight. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the uncertainty of the estimates related to the expected pro forma financial information; changes in domestic and foreign business, market, financial, political and legal conditions; the inability of the parties to successfully or timely consummate the proposed business combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed business combination or that the approval of the stockholders of Foresight or P3 is not obtained; failure to realize the anticipated benefits of the proposed business combination; risks relating to the uncertainty of the projected financial information with respect to P3; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; P3's ability to manage future growth; P3's ability to develop new products and solutions, bring them to market in a timely manner, and make enhancements to its platform; the effects of competition on P3's future business; the amount of redemption requests made by Foresight's public stockholders; the ability of Foresight or the combined company to issue equity or equity-linked securities in connection with the proposed business combination or in the future; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and those factors discussed in Foresight's Annual Report on Form 10-K for the year ended December 31, 2020 and filed with the SEC on April 6, 2021 (the "Annual Report") under the heading "Risk Factors," in the Proxy Statement under the heading "Risk Factors" and other documents of Foresight filed, or to be filed, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither P3 nor Foresight presently know or that P3 and Foresight currently believe are not material that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect P3's and Foresight's expectations, plans or forecasts of future events and views as of the date of this press release. P3 and Foresight anticipate that subsequent events and developments will cause P3's and Foresight's assessments to change. However, while P3 and Foresight may elect to update these forward-looking statements at some point in the future, P3 and Foresight specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing P3's and Foresight's assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

本新聞稿中的信息包括1995年美國私人證券訴訟改革法中“安全港”條款所指的“前瞻性陳述”。前瞻性陳述可以通過使用諸如“估計”、“計劃”、“計劃”、“預測”、“打算”、“將”、“預期”、“預期”、“相信”、“尋求”、“目標”或其他預測或指示未來事件或趨勢或不是歷史事件陳述的類似表達來識別。這些前瞻性陳述包括但不限於,有關委託書中預計的形式財務信息變化的陳述,對財務和業績指標以及預期的估計和預測,以及與潛在利益、交易條款和時機相關的時間安排。這些陳述基於各種假設,無論本新聞稿中是否提及這些假設,以及對P3公司和展望公司管理層目前的預期,並不是對實際業績的預測。這些前瞻性陳述僅供説明之用,並不打算用作任何投資者的擔保、保證、預測或對事實或可能性的明確陳述,也不得將其作為擔保、保證、預測或確鑿的事實或可能性陳述。實際事件和情況很難或不可能預測,並將與假設有所不同。許多實際事件和情況都超出了P3和Foresight的控制範圍。這些前瞻性陳述會受到一系列風險和不確定因素的影響,包括與預期的形式財務信息相關的估計的不確定性;國內外商業、市場、金融、政治和法律條件的變化;各方無法成功或及時完成擬議的業務合併的風險。, 包括未獲得、推遲或受制於可能對合並後的公司或擬議業務合併的預期效益產生不利影響的意想不到的條件的風險,或未獲得Foresight或P3股東批准的風險;未能實現擬議業務合併的預期效益;與關於P3的預測財務信息的不確定性有關的風險;未來全球、地區或地方經濟和市場狀況;法律法規的發展、影響和執行;P3管理未來增長的能力;P3開發新產品和解決方案、及時將其推向市場並增強其平臺的能力;競爭對P3未來業務的影響;Foresight的公眾股東提出的贖回請求的金額;Foresight或合併後的公司與擬議的業務合併或未來發行股本或股權掛鈎證券的能力;任何潛在訴訟、政府和監管程序、調查和詢問的結果;以及在截至2020年12月31日的年度Form 10-K中討論的因素,以及在2021年4月6日提交給美國證券交易委員會的“風險因素”標題下的年度報告(“年度報告”)、在“風險因素”標題下的委託書中討論的因素,以及在Foresight向美國證券交易委員會提交或即將提交的其他文件中討論的那些因素。如果這些風險中的任何一個成為現實,或者我們的假設被證明是錯誤的, 實際結果可能與這些前瞻性陳述所暗示的結果大不相同。可能存在P3和Foresight目前都不知道的額外風險,或者P3和Foresight目前認為不是實質性的風險,這些風險也可能導致實際結果與前瞻性陳述中包含的結果不同。此外,前瞻性陳述反映了P3和展望公司截至本新聞稿發佈之日對未來事件和觀點的預期、計劃或預測。P3和Foresight預計後續事件和發展將導致P3和Foresight的評估發生變化。然而,雖然P3和展望公司可能會選擇在未來的某個時候更新這些前瞻性陳述,但P3和展望公司明確表示不承擔任何這樣做的義務。這些前瞻性陳述不應被視為代表P3和展望公司截至本新聞稿日期之後的任何日期的評估。因此,不應過分依賴前瞻性陳述。

Additional Information About the Proposed Business Combination and Where to Find It

有關提議的業務合併的更多信息以及在哪裏可以找到它

The proposed business combination will be submitted to stockholders of Foresight for their consideration. Foresight has filed a definitive Proxy Statement with the SEC to be distributed to Foresight's stockholders in connection with Foresight's solicitation for proxies for the vote by Foresight's stockholders in connection with the proposed business combination and other matters as described in the Proxy Statement. Foresight has mailed the Proxy Statement and other relevant documents to its stockholders as of the record date established for voting on the proposed Business Combination. Foresight's stockholders and other interested persons are advised to read the Proxy Statement in connection with Foresight's solicitation of proxies for its special meeting of stockholders to be held to approve, among other things, the proposed Business Combination, because these documents contain important information about Foresight, P3 and the proposed Business Combination. Stockholders may also obtain a copy of the Proxy Statement, as well as other documents filed with the SEC regarding the proposed business combination and other documents filed with the SEC by Foresight, without charge, at the SEC's website located at www.sec.gov or by directing

擬議的業務合併將提交給Foresight的股東考慮。展望公司已經向美國證券交易委員會提交了一份最終的委託書,將分發給展望公司的股東,內容與展望公司的股東就擬議中的業務合併和委託書中描述的其他事項徵求代理人進行投票有關。展望公司已將委託書和其他相關文件郵寄給其股東,截止日期為就擬議的業務合併進行投票的記錄日期。建議Foresight的股東和其他感興趣的人士閲讀與Foresight為其股東特別會議徵求委託書有關的委託書,以批准擬議的業務合併,尤其是批准擬議的業務合併,因為這些文件包含有關Foresight、P3和擬議的業務合併的重要信息。股東還可以免費獲得委託書的副本,以及提交給美國證券交易委員會的有關擬議業務合併的其他文件,以及Foresight提交給美國證券交易委員會的其他文件,網址為www.sec.gov,或通過以下方式免費獲取美國證券交易委員會

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論